Induction of hepatic klf9 by dexamethasone promotes gluconeogenesis and hyperglycemia via PPAR activation, while klf9 knockout animals display hypoglycemia (Cui et al., 2019). The gene discussed is KLF9; the disease is Hypoglycemia.